Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
Sie sind hier:
Respirationstrakt
»
Neoplasie
26. Mai 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift:
Rect Top
Anzeige
Seite 1 von 7996
Artikel 1 - 20 / 159904
A visual analysis of the research dynamics of biomarkers for lung cancer screening.
Clin Epigenetics
Zhu H, Li B, Kong R, Yang J, Guo Z, Yin J.
PMID: 42185923 [PubMed - indexed for MEDLINE]
The landscape of MET alterations in non-small cell lung cancer in Southeastern China: a real-world study.
BMC Cancer
Zheng S, Zuo Z, Lin R, Zhang X, Huang L, Cai M, Ye Y, Yao D, Huang X.
PMID: 42185795 [PubMed - as supplied by publisher]
Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patients.
J Neurooncol
Glynn SE, D'Agostino R Jr, Lanier CM, R Choi A, Farris M, Abdulhaleem M, Young P, Wang Y, Smith M, Ruiz J, Lycan T, Petty WJ, Cramer CK, Tatter SB, Laxton AW, White JJ, Su J, T Whitlow C, Xing F, Chan MD, Helis CA.
PMID: 42185640 [PubMed - indexed for MEDLINE]
Preoperative lung immune prognostic index (LIPI) predicts postoperative outcomes in clear cell renal cell carcinoma: a multicenter study.
Sci Rep
Pan Z, Li Y, Lou J, Shan S, Guo Y, Jiang S, He Q, Zhou G, Yang L.
PMID: 42185427 [PubMed - as supplied by publisher]
Durvalumab plus anlotinib versus durvalumab alone as maintenance treatment in extensive-stage small-cell lung cancer (DURABLE): a multicenter, randomized, phase II trial and biomarker analysis.
Nat Commun
Zhang B, Zhong R, Shi C, Chu T, Zhang W, Wang H, Gan X, Zhang Z, Zhu C, Li X, Su W, Li J, Zhang Y, Han B, Zhong H.
PMID: 42185290 [PubMed - as supplied by publisher]
Mapping the home-based symptom management journey of lung cancer patients receiving combination therapy: A longitudinal qualitative study.
Eur J Oncol Nurs
Chen Q, Zhang C, Zeng Z, Ye B, Lin Q, Arbing R, Chen WT, Huang F.
PMID: 42184547 [PubMed - as supplied by publisher]
A review of deep learning-based multimodal data integration of lung cancer.
Clin Exp Med
Qin Y, Wang S, Wu D, Fei Y, Ding W, Wang Q, Guan R, Liang X.
PMID: 42184020 [PubMed - as supplied by publisher]
A Genomic and Epigenetic Comparative Study of Low-grade Biphenotypic Sinonasal Sarcoma with Metachronous and Synchronous High-grade Rhabdomyosarcomatous Transformation.
Head Neck Pathol
Sibira RM, Chen C, Costa FA, Verma A, Singh P, Peterson JE, Hattery T, Racila E, Zhong M, Murugan P, Dermawan JK.
PMID: 42183964 [PubMed - indexed for MEDLINE]
Neural Correlates of Palliative Care: A Feasibility Trial in Patients with Metastatic Gastrointestinal and Lung Cancer.
Res Sq
Fanouraki E, Knotts JD, Page CA, Perry A, Wager TD, Wheatley TP, Ahern C, Barnato AE.
PMID: 42183384 [PubMed]
Encounter tool for Shared Decision Making about Adjuvant Treatment of Lung Cancer: Randomized Clinical Trial.
Res Sq
Bandi SSS, Branda ME, Chavez MM, Bagewadi S, Norman AS, Montori V, Gionfriddo MR, Hargraves IG, Boehmer K, Stephen A, Sagen C, Montori VM, Brito JP, Leventakos K.
PMID: 42183367 [PubMed]
Machine learning-based prediction of mortality in lung cancer: Application of severity-adjustment method.
Digit Health
Park S, Woo S, Park JH, Park B, Lee M.
PMID: 42183301 [PubMed]
Vaccinia virus for lung cancer therapy: preclinical progress and prospects as a systemic immunotherapy platform.
Front Immunol
Li L, Chen Z, Yan Y, Zhang L.
PMID: 42183276 [PubMed - indexed for MEDLINE]
Multi-omics biomarkers for predicting resistance, hyperprogression, and immune-related toxicity during PD-1/PD-L1 therapy in lung cancer: a literature review.
Front Immunol
Hu N, Wang Z, Liu M, Guo D, Jiang C, Chen Y, Zhang Z, Bai M, Cheng B, Hsu JC, Wu L, Sui X.
PMID: 42183274 [PubMed - indexed for MEDLINE]
A blood-based immune-suppressive index stratifies immunotherapy outcomes in advanced NSCLC.
Front Immunol
Lalli L, Huber V, Cova A, Daveri E, Listì A, Rossi G, Genova C, Coco S, Baraibar I, Gil-Bazo I, Novello S, Rivoltini L, Passiglia F.
PMID: 42183256 [PubMed - indexed for MEDLINE]
Case Report: Neuroendocrine-marker-negative high-grade neuroendocrine carcinoma mimicking squamous cell carcinoma: an underrecognized diagnostic pitfall.
Front Immunol
He W, Tang Y, Li Y, Zhang J, You X, Wu Q.
PMID: 42183205 [PubMed - indexed for MEDLINE]
Functional role of long non-coding RNA MALAT1 and HOTAIR in lung cancer.
Noncoding RNA Res
Wen HW, Afzal A, Chen GW, Saeed G, An Y, Sun SC, Rehman A, Jamil MU, Saddozai UAK, Zhang L, Ma F, Ji XY, Khawar MB.
PMID: 42183023 [PubMed]
The role of growth heterogeneity in solid nodular non-small cell lung cancer in clinical practice: a narrative review.
J Thorac Dis
Chen J, Wang J.
PMID: 42182806 [PubMed]
Lung cancer incidence and risk factors in chronic obstructive pulmonary disease: a systematic review and meta-analysis of cohort studies.
J Thorac Dis
Gong X, Zhao Z, Yuan Y.
PMID: 42182791 [PubMed]
Screening air pollutants-related genes to construct a prognostic risk model for lung adenocarcinoma and analyzing its immune microenvironment.
J Thorac Dis
Tang Z, Ye J, Chen D.
PMID: 42182790 [PubMed]
Advancing lung adenocarcinoma diagnosis using peri-nodular features: a CT radiomics study for determining invasiveness in sub-centimeter pure ground glass nodules.
J Thorac Dis
Han C, Shi G, Ren J, Li H, Li Y.
PMID: 42182781 [PubMed]
Artikel 1 - 20 / 159904
Seite 1 von 7996
Rect Bottom
Anzeige
Adserver Footer
Zeitfenster
--unbegrenzt--
1 Woche
1 Monat
3 Monate
6 Monate
1 Jahr
2 Jahre
3 Jahre
5 Jahre
10 Jahre
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Datenschutzerklärung / Privacy Policy
|
Werbung